A native interactor scaffolds and stabilizes toxic ATAXIN-1 oligomers in SCA1Cristian A. Lasagna‐Reeves, Huda Y. Zoghbi, Paymaan Jafar‐Nejad et al.|eLife|2015Cited by 45
Characterizing the differential distribution and targets of Sumo1 and Sumo2 in the mouse brainTerry R. Suk, Maxime W.C. Rousseaux|iScience|2023Cited by 12
Genetic and pharmacological reduction of CDK14 mitigates synucleinopathyJean-Louis Parmasad, Maxime W.C. Rousseaux|Cell Death and Disease|2024Cited by 6
Characterizing the differential distribution and targets of Sumo paralogs in the mouse brainTerry R. Suk, Maxime W.C. Rousseaux|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 2
Genetic and pharmacological reduction of CDK14 mitigates α-synuclein pathology in human neurons and in rodent models of Parkinson’s diseaseJean-Louis Parmasad, Maxime W.C. Rousseaux|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 1